Intersect ENT (XENT) Misses Q3 EPS by 6c

Intersect ENT (NASDAQ: XENT) reported Q3 EPS of ($0.35), $0.06 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $14.2 million versus the consensus estimate of $14.8 million.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Beam Global reports Q2 2026 revenue above $8.5M, up 170% from Q1
• Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene